carvedilol has been researched along with Cardiomyopathy, Congestive in 136 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study aimed to evaluate the clinical efficacy and safety of carvedilol for pediatric patients with chronic heart failure caused by dilated cardiomyopathy." | 9.17 | The effect of carvedilol treatment on chronic heart failure in pediatric patients with dilated cardiomyopathy: a prospective, randomized-controlled study. ( Chen, S; Huang, M; Liu, F; Sun, J; Sun, Y; Xiao, Y; Zhang, X, 2013) |
| "Carvedilol therapy appears to be safe for patients with DCM secondary to muscular dystrophy and produces a modest improvement in systolic and diastolic function." | 9.13 | Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy. ( Colan, SD; Darras, BT; Geva, T; Jenkins, KJ; Margossian, R; Powell, AJ; Rhodes, J, 2008) |
| "Fourteen digitalised patients diagnosed with heart failure (NYHA Functional class II) with idiopathic dilated cardiomyopathy in chronic established atrial fibrillation were administered carvedilol in addition to their anti-heart failure medications in an attempt to improve their heart rate control." | 9.09 | Beneficial effect of carvedilol on heart rate response to exercise in digitalised patients with heart failure in atrial fibrillation due to idiopathic dilated cardiomyopathy. ( Agarwal, AK; Venugopalan, P, 2001) |
| "The present study demonstrates that during long-term therapy, carvedilol improves cardiac performance to a greater extent than metoprolol when administered to patients with heart failure in the doses shown to be effective in clinical trials." | 9.09 | Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol. ( Boldi, E; Dei Cas, L; Giubbini, R; Metra, M; Modena, MG; Nodari, S, 2000) |
| "We conclude that the addition of carvedilol to standard therapy can improve clinical symptoms and heart rate variability, and reduce in arrhythmia markers in children with DCM." | 7.79 | Effects of carvedilol therapy on cardiac autonomic control, QT dispersion, and ventricular arrhythmias in children with dilated cardiomyopathy. ( Akdeniz, C; Balli, S; Ece, I; Kibar, AE; Oflaz, MB; Tuzcu, V, 2013) |
| "Carvedilol is a safe complement to standard therapy for heart failure in children, allowing a significant reduction of neurohormonal activation with evident benefits on both ventricular function and the clinical condition." | 7.72 | Modulation of neurohormonal activity after treatment of children in heart failure with carvedilol. ( Bonvicini, M; Bronzetti, G; Donti, A; Formigari, R; Giardini, A; Picchio, FM; Prandstraller, D, 2003) |
| "In this study we observed that carvedilol administration to patients with heart failure improves hemodynamic function, baroreflex sensitivity, and heart rate variability." | 7.70 | Effects of carvedilol on heart rate and blood pressure variability in subjects with chronic heart failure. ( Cacciafesta, M; Celli, V; Lionetti, M; Luparini, RL; Marigliano, V; Moisè, A; Piccirillo, G, 2000) |
| "Thirty consecutive DCM patients with persistent LV dysfunction (ejection fraction < or =40%) and reduced exercise tolerance (peak oxygen consumption <25 ml/kg/min) despite chronic (>1 year) tailored treatment with metoprolol and angiotensin-converting enzyme inhibitors were enrolled in a 12-month, open-label, parallel trial and were randomized either to continue on metoprolol (n = 16, mean dosage 142+/-44 mg/day) or to cross over to maximum tolerated dosage of carvedilol (n = 14, mean dosage 74+/-23 mg/day)." | 6.69 | Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group. ( Camerini, F; Ciani, F; Di Lenarda, A; Gregori, D; Klugmann, S; Mestroni, L; Muzzi, A; Pinamonti, B; Sabbadini, G; Salvatore, L; Sinagra, G, 1999) |
| "Carvedilol was started at a dose of 3." | 5.31 | [Reversibility of left ventricular dysfunction in elderly patients with dilated cardiomyopathy undergoing treatment with carvedilol. Report of a case]. ( Cioffi, G; Stefenelli, C, 2001) |
| "This study aimed to evaluate the clinical efficacy and safety of carvedilol for pediatric patients with chronic heart failure caused by dilated cardiomyopathy." | 5.17 | The effect of carvedilol treatment on chronic heart failure in pediatric patients with dilated cardiomyopathy: a prospective, randomized-controlled study. ( Chen, S; Huang, M; Liu, F; Sun, J; Sun, Y; Xiao, Y; Zhang, X, 2013) |
| "Carvedilol therapy appears to be safe for patients with DCM secondary to muscular dystrophy and produces a modest improvement in systolic and diastolic function." | 5.13 | Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy. ( Colan, SD; Darras, BT; Geva, T; Jenkins, KJ; Margossian, R; Powell, AJ; Rhodes, J, 2008) |
| "The purpose of the study was to evaluate the influence of metoprolol succinate and carvedilol on the physical ability (FA) of patients with chronic heart failure (CHF) of different etiologies." | 5.12 | [The effects of beta-adrenoblocker therapy on the physical working capacity of patients with chronic heart failure of various origin]. ( Andreev, DA; Kalashnikov, VIu; Poltavskaia, MG; Sarkisova, EA; Svet, AV; Syrkin, AL, 2007) |
| "beta-adrenergic receptor antagonism with drugs like carvedilol slows the progression of heart failure by an undefined mechanism." | 5.12 | The effect of beta-adrenergic receptor antagonism in cardiac sympathetic neuronal remodeling in patients with heart failure. ( Bocchi, EA; Chizzola, PR; Gonçalves de Freitas, HF; Mansur, JA; Marinho, NV; Meneghetti, JC, 2006) |
| "The aim of this study was to investigate in dialysis patients with symptomatic heart failure New York Heart Association (NYHA) functional class II or III whether the addition of carvedilol to conventional therapy is associated with beneficial effects on cardiac architecture, function and clinical status." | 5.09 | Dilated cardiomyopathy in dialysis patients--beneficial effects of carvedilol: a double-blind, placebo-controlled trial. ( Cice, G; Di Benedetto, A; Ferrara, L; Iacono, A; Marinelli, G; Pavese, F; Russo, PE, 2001) |
| "Fourteen digitalised patients diagnosed with heart failure (NYHA Functional class II) with idiopathic dilated cardiomyopathy in chronic established atrial fibrillation were administered carvedilol in addition to their anti-heart failure medications in an attempt to improve their heart rate control." | 5.09 | Beneficial effect of carvedilol on heart rate response to exercise in digitalised patients with heart failure in atrial fibrillation due to idiopathic dilated cardiomyopathy. ( Agarwal, AK; Venugopalan, P, 2001) |
| "The present study demonstrates that during long-term therapy, carvedilol improves cardiac performance to a greater extent than metoprolol when administered to patients with heart failure in the doses shown to be effective in clinical trials." | 5.09 | Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol. ( Boldi, E; Dei Cas, L; Giubbini, R; Metra, M; Modena, MG; Nodari, S, 2000) |
| " Initial treatment of their acute heart failure was successful in all 5 but 4 patients relapsed despite the usual dose of carvedilol (induction 0." | 3.83 | Left ventricular reverse remodeling with infantile dilated cardiomyopathy and pitfalls of carvedilol therapy. ( Abe, T; Iwasa, T; Negishi, J; Noritake, K; Tsuda, E, 2016) |
| "We conclude that the addition of carvedilol to standard therapy can improve clinical symptoms and heart rate variability, and reduce in arrhythmia markers in children with DCM." | 3.79 | Effects of carvedilol therapy on cardiac autonomic control, QT dispersion, and ventricular arrhythmias in children with dilated cardiomyopathy. ( Akdeniz, C; Balli, S; Ece, I; Kibar, AE; Oflaz, MB; Tuzcu, V, 2013) |
| "Carvedilol is a safe complement to standard therapy for heart failure in children, allowing a significant reduction of neurohormonal activation with evident benefits on both ventricular function and the clinical condition." | 3.72 | Modulation of neurohormonal activity after treatment of children in heart failure with carvedilol. ( Bonvicini, M; Bronzetti, G; Donti, A; Formigari, R; Giardini, A; Picchio, FM; Prandstraller, D, 2003) |
| " The cardioprotective properties of carvedilol, a vasodilating beta-adrenoceptor-blocking agent, were studied in a rat model of dilated cardiomyopathy after autoimmune myocarditis." | 3.71 | Effects of carvedilol on cardiac function and cardiac adrenergic neuronal damage in rats with dilated cardiomyopathy. ( Aizawa, Y; Ashino, H; Fuse, K; Kodama, M; Nakazawa, M; Takahashi, T; Tanabe, N; Tazawa, S; Wahed, MI; Watanabe, K, 2002) |
| "In this study we observed that carvedilol administration to patients with heart failure improves hemodynamic function, baroreflex sensitivity, and heart rate variability." | 3.70 | Effects of carvedilol on heart rate and blood pressure variability in subjects with chronic heart failure. ( Cacciafesta, M; Celli, V; Lionetti, M; Luparini, RL; Marigliano, V; Moisè, A; Piccirillo, G, 2000) |
| "The cardioprotective properties of carvedilol (a vasodilating beta-adrenoceptor blocking agent) were studied in a rat model of dilated cardiomyopathy induced by autoimmune myocarditis." | 3.70 | Low dose carvedilol inhibits progression of heart failure in rats with dilated cardiomyopathy. ( Aizawa, Y; Fuse, K; Hanawa, H; Hasegawa, G; Higuchi, H; Hirono, S; Ito, M; Kato, K; Kodama, M; Naito, M; Nakazawa, M; Ohta, Y; Tanabe, N; Watanabe, K, 2000) |
| "The aim of the present study was to assess the effects of carvedilol therapy in addition to conventional heart failure therapy on heart rate variability (HRV) and on left ventricular function in 14 patients with mild to moderate heart failure due to idiopathic dilated cardiomyopathy (IDC)." | 3.70 | [Prospective evaluation of effect of carvedilol therapy on heart rate variability in patients with dilated cardiomyopathy]. ( Grimm, W; Hoffmann, J; Hufnagel, G; Maisch, B; Menz, V, 1999) |
| "At present, the therapies of dilated cardiomyopathy concentrated on the symptoms of heart failure and related complications." | 3.01 | Comparative Efficacy of Different Drugs for the Treatment of Dilated Cardiomyopathy: A Systematic Review and Network Meta-analysis. ( Chang, S; Lu, S; Shen, L; Tong, X; Wang, Y; Zhou, X, 2023) |
| "Reverse ventricular remodeling obtained with carvedilol, ramipril/candesartan, and spironolacton is associated with decreases in left ventricular end-diastolic volume, left ventricular end-systolic volume, tenascin-C levels, and NT-proBNP levels." | 2.78 | Tenascin-C as predictor of left ventricular remodeling and mortality in patients with dilated cardiomyopathy. ( Akpek, M; Kaya, EG; Kaya, MG; Lam, YY; Sarli, B; Topsakal, R, 2013) |
| "We included 35 patients with idiopathic dilated cardiomyopathy with an ejection fraction (EF) <40% and heart rate >70 beats/min despite optimal medical therapy, according to the international guidelines in this prospective, non-randomized, single-arm, open-label safety study." | 2.76 | Ivabradine, a novel heart rate slower: is it a sword of double blades in patients with idiopathic dilated cardiomyopathy? ( Alabd, A; Gamal, A; Rayan, M; Tawfik, M, 2011) |
| "Oral carvedilol was added to a standard regimen of an angiotensin-converting enzyme inhibitor, a diuretic, and digoxin in a dose-escalation design." | 2.73 | Effects of carvedilol on left ventricular function and oxidative stress in infants and children with idiopathic dilated cardiomyopathy: a 12-month, two-center, open-label study. ( Bajcetic, M; Djukic, M; Jovanovic, I; Kokic Nikolic, A; Kosutic, J; Mijalkovic, D; Mitrovic, J; Samardzic, R; Simeunovic, S; Spasic, MB, 2008) |
| "In patients with dilated cardiomyopathy, the addition of carvedilol to treatment with digoxin, ACE inhibitors and diuretics is associated with a significant improvement in symptoms and in LV function, and suppression of inflammatory cytokines." | 2.71 | A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy. ( Kurum, T; Tatli, E, 2005) |
| "Carvedilol treatment can improve cardiac function, symptoms, and cardiac sympathetic nerve activity in patients with DCM to a similar extent as metoprolol treatment." | 2.71 | Efficacy of carvedilol treatment on cardiac function and cardiac sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with metoprolol therapy. ( Adachi, H; Hoshizaki, H; Isobe, N; Naito, S; Oshima, S; Seki, R; Taniguchi, K; Toyama, T, 2003) |
| "A total of 114 dialysis patients with dilated cardiomyopathy were randomized to receive either carvedilol or placebo in addition to standard therapy." | 2.71 | Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial. ( Calabrò, R; Cice, G; Cittadini, A; D'Andrea, A; D'Isa, S; Di Benedetto, A; Ferrara, L; Golino, P; Russo, PE, 2003) |
| "In patients with idiopathic dilated cardiomyopathy, the addition of pentoxifylline to treatment with digoxin, ACE inhibitors, and carvedilol is associated with a significant improvement in symptoms and left ventricular function." | 2.70 | Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study. ( Bergemann, A; Candy, G; Sareli, P; Skudicky, D; Sliwa, K, 2001) |
| "Metoprolol was administered to 29 patients, and carvedilol to 62." | 2.70 | Comparative left ventricular functional and neurohumoral effects of chronic treatment with carvedilol versus metoprolol in patients with dilated cardiomyopathy. ( Hanatani, A; Hirooka, K; Hori, M; Ishida, Y; Komamura, K; Miyatake, K; Nakatani, S; Yamagishi, M; Yasumura, Y, 2001) |
| "In idiopathic dilated cardiomyopathy, functional improvement related to treatment with beta-blockers is associated with changes in myocardial gene expression." | 2.70 | Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. ( Abraham, WT; Bristow, MR; Ferguson, D; Gilbert, EM; Larrabee, P; Lindenfeld, J; Lowes, BD; Minobe, WA; Quaife, RA; Robertson, AD; Tsvetkova, T; Wolfel, EE, 2002) |
| "Thirty consecutive DCM patients with persistent LV dysfunction (ejection fraction < or =40%) and reduced exercise tolerance (peak oxygen consumption <25 ml/kg/min) despite chronic (>1 year) tailored treatment with metoprolol and angiotensin-converting enzyme inhibitors were enrolled in a 12-month, open-label, parallel trial and were randomized either to continue on metoprolol (n = 16, mean dosage 142+/-44 mg/day) or to cross over to maximum tolerated dosage of carvedilol (n = 14, mean dosage 74+/-23 mg/day)." | 2.69 | Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group. ( Camerini, F; Ciani, F; Di Lenarda, A; Gregori, D; Klugmann, S; Mestroni, L; Muzzi, A; Pinamonti, B; Sabbadini, G; Salvatore, L; Sinagra, G, 1999) |
| "Carvedilol treatment improved ventricular function and reduced the incidence of arrhythmic episodes." | 2.69 | Efficacy of carvedilol on complex ventricular arrhythmias in dilated cardiomyopathy: double-blind, randomized, placebo-controlled study. ( Cice, G; Ferrara, L; Iacono, A; Tagliamonte, E, 2000) |
| "Carvedilol was added to the usual therapy of 20 patients; placebo was added to the usual therapy of 10 patients." | 2.69 | Effects of carvedilol in heart failure due to dilated cardiomyopathy. Results of a double-blind randomized placebo-controlled study (CARIBE study). ( Bocchi, EA; Caldas, MA; Chizzola, PR; da Costa, JM; Freitas, HF; Mansur, AJ; Marinho, NV; Meneghetti, C; Ramires, JA, 2000) |
| "Carvedilol has been shown to determine a significant improvement in left ventricular function, symptoms, clinical course and prognosis of patients with chronic heart failure." | 2.68 | [The effects of mid- and long-term administration (3-4 years) of carvedilol in patients with idiopathic dilated cardiomyopathy]. ( Boldi, E; Dei Cas, L; Garbellini, M; Giubbini, R; Metra, M; Milan, E; Nodari, S; Rosselli, F, 1997) |
| "Forty patients with idiopathic dilated cardiomyopathy treated with digoxin, furosemide and angiotensin-converting enzyme inhibitors were randomized in a double-blind manner to receive either placebo or carvedilol." | 2.67 | Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy. ( Dei Cas, L; Giubbini, R; Metra, M; Nardi, M, 1994) |
| "The treatment of heart failure has changed with the use of angiotensin-converting enzyme inhibitors (ACEIs) and beta-blockers since the middle of the 1990s." | 1.51 | Improvement of the outcome in patients with infantile dilated cardiomyopathy over three decades - The usefulness of long-term gradually medical supportive care. ( Kitano, M; Tsuda, E; Yamada, O, 2019) |
| "Echocardiography showed 73% dilated cardiomyopathy; 83% showed moderate to severe LV systolic dysfunction (mean EF 36." | 1.43 | Clinical and echocardiographic characteristics and outcomes in congestive heart failure at the Hospital of The State University of Haiti. ( Malebranche, R; Morisset, PH; Raphael, NA; Tabou Moyo, C; Wilentz, JR, 2016) |
| "Children receiving carvedilol for treatment of dilated cardiomyopathy with moderate to severe ventricular dysfunction were included into the study." | 1.39 | Clinical and echocardiographic outcome in patients receiving carvedilol for treatment of dilated cardiomyopathy. ( Anil, OM; Juneja, R; Saxena, A, 2013) |
| "Forty-two patients with idiopathic dilated cardiomyopathy treated with the therapy were studied." | 1.37 | Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy. ( Doi, YL; Furuno, T; Hoshikawa, E; Kitaoka, H; Kubo, T; Matsumura, Y; Okawa, M; Takata, J; Yamasaki, N, 2011) |
| "A 43-year-old Japanese woman with dilated cardiomyopathy had complete left ventricular bundle branch block (CLBBB), which had persisted for at least two years." | 1.35 | Persistent left bundle branch block in a patient with dilated cardiomyopathy that improved with low dose carvedilol therapy. ( Hiraiwa, Y; Kaku, B; Katsuda, S; Nakatani, Y; Nitta, Y; Sato, T; Taguchi, T, 2008) |
| "In patients with nonischemic dilated cardiomyopathy, carvedilol leads to a significantly greater improvement in LVEF in patients with the Arg389Arg-beta1 adrenergic receptor phenotype." | 1.34 | Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol. ( Atherton, J; Burstow, D; Chen, L; Fong, KM; Galbraith, AJ; Javorsky, G; Lolekha, P; Lucas, M; Meyers, D; Molenaar, P; Parsonage, WA; Savarimuthu, SM; Semmler, AB; Yang, IA, 2007) |
| "We report a case of dilated cardiomyopathy with mechanical alternans." | 1.34 | Decline of plasma brain natriuretic peptide level after carvedilol therapy to treat dilated cardiomyopathy presenting with mechanical alternans. ( Mori, K; Oe, K; Yamagata, T, 2007) |
| "The carvedilol effect was more pronounced in patients with nonischemic dilated cardiomyopathy than in those with ischemic disease." | 1.34 | Effects of carvedilol on plasma levels of pro-inflammatory cytokines in patients with ischemic and nonischemic dilated cardiomyopathy. ( Kurum, T; Tatli, E; Yuksel, M, 2007) |
| "Fifty consecutive patients with dilated cardiomyopathy in NYHA class II-IV with a left ventricular ejection fraction (LVEF) of 35% or below were studied with full polysomnography over one night." | 1.34 | Does beta-blocker treatment influence central sleep apnoea? ( Köhnlein, T; Welte, T, 2007) |
| "He was diagnosed with dilated cardiomyopathy." | 1.33 | Dilated cardiomyopathy relieved as a result of beta-blocker therapy: a case report--key points in assessment of prognosis based on MIBG myocardial scintigraphy and BNP levels. ( Horie, M; Masuda, D; Matsumoto, T; Matsuo, S; Nakae, I, 2005) |
| "Carvedilol was initiated 14." | 1.32 | Carvedilol in children with cardiomyopathy: 3-year experience at a single institution. ( Gómez-Marín, O; Lon-Young, M; Marín, JR; Redha, E; Rossique-González, M; Rusconi, P; Wolff, GS, 2004) |
| "Forty-two patients with dilated cardiomyopathy were given carvedilol for 3 to 5 months." | 1.31 | Improvement in left ventricular function in response to carvedilol is accompanied by attenuation of neurohumoral activation in patients with dilated cardiomyopathy. ( Fujimura, M; Ishida, Y; Komamura, K; Miyatake, K; Nakatani, S; Yamagishi, M; Yasumura, Y, 2000) |
| "A 27-year-old man diagnosed as having dilated cardiomyopathy (DCM) without myocardial accumulation of 123I-beta-methyl-iodophenylpentadecanoic acid, and he was found to have type I CD36 deficiency." | 1.31 | Improvement in cardiac function and free fatty acid metabolism in a case of dilated cardiomyopathy with CD36 deficiency. ( Hanatani, A; Hirooka, K; Ishida, Y; Komamura, K; Miyatake, K; Nakatani, S; Yamagishi, M; Yasumura, Y, 2000) |
| "Carvedilol was started at a dose of 3." | 1.31 | [Reversibility of left ventricular dysfunction in elderly patients with dilated cardiomyopathy undergoing treatment with carvedilol. Report of a case]. ( Cioffi, G; Stefenelli, C, 2001) |
| "Nine patients with idiopathic dilated cardiomyopathy, who had previously received conventional treatment and were classified as New York Heart Association (NYHA) functional class II, received carvedilol by stepwise dose increase up to 20 mg daily, and the plasma interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) levels were measured." | 1.31 | Effects of carvedilol on plasma levels of interleukin-6 and tumor necrosis factor-alpha in nine patients with dilated cardiomyopathy. ( Asano, R; Hosoda, S; Kitahara, K; Matsumura, T; Misu, K; Nagayama, M; Ohtaki, E; Sumiyoshi, T; Tohbaru, T; Tsushima, K; Umemura, J, 2002) |
| "Carvedilol is a high-affinity, slightly beta 1-selective competitive beta-blocking agent, with a KD for beta 1-receptors of approximately 4-5 nM and a selectivity of sixfold to 39-fold for beta 1-receptors rather than beta 2-receptors, depending on the method used to assess subtype potency." | 1.28 | Receptor pharmacology of carvedilol in the human heart. ( Bristow, MR; Handwerger, D; Klein, J; Larrabee, P; Minobe, W; Müller-Beckmann, B; Port, JD; Roden, R; Skerl, L, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 18 (13.24) | 18.2507 |
| 2000's | 93 (68.38) | 29.6817 |
| 2010's | 24 (17.65) | 24.3611 |
| 2020's | 1 (0.74) | 2.80 |
| Authors | Studies |
|---|---|
| Tong, X | 1 |
| Shen, L | 1 |
| Zhou, X | 1 |
| Wang, Y | 2 |
| Chang, S | 1 |
| Lu, S | 1 |
| Sarkar, R | 1 |
| Paul, R | 1 |
| Roy, D | 1 |
| Saha, A | 1 |
| Sau, TJ | 1 |
| Mondal, J | 1 |
| Tsuda, E | 3 |
| Yamada, O | 1 |
| Kitano, M | 1 |
| Li, T | 1 |
| Yuan, G | 1 |
| Ma, C | 1 |
| Jin, P | 1 |
| Zhou, C | 1 |
| Li, W | 1 |
| Saxena, A | 1 |
| Anil, OM | 1 |
| Juneja, R | 1 |
| Sarli, B | 2 |
| Topsakal, R | 2 |
| Kaya, EG | 2 |
| Akpek, M | 2 |
| Lam, YY | 2 |
| Kaya, MG | 2 |
| Oflaz, MB | 1 |
| Balli, S | 1 |
| Kibar, AE | 1 |
| Ece, I | 1 |
| Akdeniz, C | 1 |
| Tuzcu, V | 1 |
| Yarlioglues, M | 1 |
| Tanaka, H | 1 |
| Matsumoto, K | 1 |
| Sawa, T | 1 |
| Miyoshi, T | 1 |
| Motoji, Y | 1 |
| Imanishi, J | 1 |
| Mochizuki, Y | 1 |
| Tatsumi, K | 1 |
| Hirata, K | 1 |
| Ikeda, Y | 1 |
| Inomata, T | 1 |
| Iida, Y | 1 |
| Iwamoto-Ishida, M | 1 |
| Nabeta, T | 1 |
| Ishii, S | 1 |
| Sato, T | 2 |
| Yanagisawa, T | 1 |
| Mizutani, T | 1 |
| Naruke, T | 1 |
| Koitabashi, T | 1 |
| Takeuchi, I | 1 |
| Nishii, M | 1 |
| Ako, J | 1 |
| Negishi, J | 1 |
| Noritake, K | 1 |
| Iwasa, T | 1 |
| Abe, T | 1 |
| Motoki, N | 1 |
| Inaba, Y | 1 |
| Matsuzaki, S | 1 |
| Akazawa, Y | 1 |
| Nishimura, T | 1 |
| Fukuyama, T | 1 |
| Koike, K | 1 |
| Wyles, SP | 1 |
| Hrstka, SC | 1 |
| Reyes, S | 1 |
| Terzic, A | 1 |
| Olson, TM | 1 |
| Nelson, TJ | 1 |
| Malebranche, R | 1 |
| Tabou Moyo, C | 1 |
| Morisset, PH | 1 |
| Raphael, NA | 1 |
| Wilentz, JR | 1 |
| Nakamura, T | 2 |
| Fujita, T | 1 |
| Kishimura, M | 1 |
| Suita, K | 1 |
| Hidaka, Y | 1 |
| Cai, W | 1 |
| Umemura, M | 1 |
| Yokoyama, U | 1 |
| Uechi, M | 1 |
| Ishikawa, Y | 1 |
| Crespo, MJ | 1 |
| Cruz, N | 1 |
| Altieri, PI | 1 |
| Escobales, N | 1 |
| Calişkan, M | 1 |
| Ciftçi, O | 1 |
| Güllü, H | 1 |
| Müderrisoğlu, H | 1 |
| Cadrin-Tourigny, J | 1 |
| Fournier, A | 1 |
| Andelfinger, G | 1 |
| Khairy, P | 1 |
| Chua, S | 1 |
| Sheu, JJ | 1 |
| Chang, LT | 1 |
| Lee, FY | 1 |
| Wu, CJ | 1 |
| Sun, CK | 1 |
| Yip, HK | 1 |
| Naya, M | 1 |
| Tsukamoto, T | 1 |
| Morita, K | 1 |
| Katoh, C | 1 |
| Nishijima, K | 1 |
| Komatsu, H | 1 |
| Yamada, S | 1 |
| Kuge, Y | 1 |
| Tamaki, N | 1 |
| Tsutsui, H | 1 |
| Barison, A | 1 |
| Aquaro, GD | 1 |
| Passino, C | 1 |
| Falorni, M | 1 |
| Balbarini, A | 1 |
| Lombardi, M | 1 |
| Pasquali, L | 1 |
| Emdin, M | 1 |
| Siciliano, G | 1 |
| Altenberger, H | 1 |
| Stöllberger, C | 1 |
| Finsterer, J | 1 |
| Zhan, DY | 1 |
| Morimoto, S | 1 |
| Du, CK | 1 |
| Wang, YY | 1 |
| Lu, QW | 1 |
| Tanaka, A | 1 |
| Ide, T | 1 |
| Miwa, Y | 1 |
| Takahashi-Yanaga, F | 1 |
| Sasaguri, T | 1 |
| Aguilar-Torres, R | 1 |
| Parker, T | 1 |
| Ito, T | 1 |
| Kawanishi, Y | 1 |
| Futai, R | 1 |
| Terasaki, F | 1 |
| Kitaura, Y | 1 |
| Chandar, S | 1 |
| Yeo, LS | 1 |
| Leimena, C | 1 |
| Tan, JC | 1 |
| Xiao, XH | 1 |
| Nikolova-Krstevski, V | 1 |
| Yasuoka, Y | 1 |
| Gardiner-Garden, M | 1 |
| Wu, J | 1 |
| Kesteven, S | 1 |
| Karlsdotter, L | 1 |
| Natarajan, S | 1 |
| Carlton, A | 1 |
| Rainer, S | 1 |
| Feneley, MP | 2 |
| Fatkin, D | 2 |
| Matsuo, M | 1 |
| Sakaguchi, H | 1 |
| Hayashi, T | 1 |
| Hosoda, K | 1 |
| Miyazaki, A | 1 |
| Fan, Y | 1 |
| Lin, JH | 1 |
| Dong, G | 1 |
| Zhu, J | 1 |
| Yin, F | 1 |
| Yang, SS | 1 |
| Talan, MI | 1 |
| Ahmet, I | 1 |
| Xiao, RP | 1 |
| Lakatta, EG | 1 |
| Wojnicz, R | 1 |
| Nowak, J | 1 |
| Lekston, A | 1 |
| Wilczewski, P | 1 |
| Nowalany-Kozielska, E | 1 |
| Streb, W | 1 |
| Wojciechowska, C | 1 |
| Stolarz, W | 1 |
| Helewski, K | 1 |
| Szyguła-Jurkiewicz, B | 1 |
| Poloński, L | 1 |
| Hoshikawa, E | 1 |
| Matsumura, Y | 4 |
| Kubo, T | 1 |
| Okawa, M | 1 |
| Yamasaki, N | 1 |
| Kitaoka, H | 1 |
| Furuno, T | 1 |
| Takata, J | 1 |
| Doi, YL | 1 |
| Rayan, M | 1 |
| Tawfik, M | 1 |
| Alabd, A | 1 |
| Gamal, A | 1 |
| Yeoh, T | 1 |
| Hayward, C | 1 |
| Benson, V | 1 |
| Sheu, A | 1 |
| Richmond, Z | 1 |
| Keogh, AM | 2 |
| Macdonald, P | 1 |
| Muñiz, AE | 1 |
| Huang, M | 2 |
| Zhang, X | 1 |
| Chen, S | 2 |
| Sun, Y | 1 |
| Xiao, Y | 1 |
| Sun, J | 1 |
| Liu, F | 1 |
| Hara, Y | 5 |
| Hamada, M | 4 |
| Ohtsuka, T | 5 |
| Ogimoto, A | 5 |
| Saeki, H | 3 |
| Suzuki, J | 1 |
| Matsunaka, T | 1 |
| Nakata, S | 2 |
| Shigematsu, Y | 5 |
| Abraham, WT | 3 |
| Gilbert, EM | 4 |
| Lowes, BD | 4 |
| Minobe, WA | 2 |
| Larrabee, P | 5 |
| Roden, RL | 1 |
| Dutcher, D | 1 |
| Sederberg, J | 1 |
| Lindenfeld, JA | 1 |
| Wolfel, EE | 2 |
| Shakar, SF | 1 |
| Ferguson, D | 3 |
| Volkman, K | 2 |
| Linseman, JV | 1 |
| Quaife, RA | 3 |
| Robertson, AD | 3 |
| Bristow, MR | 8 |
| Metra, M | 4 |
| Nodari, S | 3 |
| Parrinello, G | 1 |
| Giubbini, R | 4 |
| Manca, C | 1 |
| Dei Cas, L | 4 |
| Higaki, J | 3 |
| Cice, G | 3 |
| Ferrara, L | 3 |
| D'Andrea, A | 1 |
| D'Isa, S | 1 |
| Di Benedetto, A | 2 |
| Cittadini, A | 1 |
| Russo, PE | 2 |
| Golino, P | 1 |
| Calabrò, R | 1 |
| Ratnapalan, S | 1 |
| Griffiths, K | 1 |
| Costei, AM | 1 |
| Benson, L | 1 |
| Koren, G | 1 |
| Maunoury, C | 1 |
| Acar, P | 1 |
| Sidi, D | 1 |
| Toyama, T | 3 |
| Hoshizaki, H | 1 |
| Seki, R | 1 |
| Isobe, N | 1 |
| Adachi, H | 1 |
| Naito, S | 1 |
| Oshima, S | 1 |
| Taniguchi, K | 1 |
| Hanrath, P | 1 |
| Schneider, CA | 1 |
| Palazzuoli, A | 1 |
| Carrera, A | 1 |
| Calabria, P | 1 |
| Puccetti, L | 1 |
| Pastrorelli, M | 1 |
| Pasqui, AL | 1 |
| Auteri, A | 1 |
| Bruni, F | 1 |
| Giardini, A | 1 |
| Formigari, R | 1 |
| Bronzetti, G | 1 |
| Prandstraller, D | 1 |
| Donti, A | 1 |
| Bonvicini, M | 1 |
| Picchio, FM | 1 |
| Watanabe, K | 3 |
| Abe, Y | 1 |
| Sato, S | 1 |
| Wahed, M | 1 |
| Wen, J | 1 |
| Narasimman, G | 1 |
| Ma, M | 1 |
| Ali, F | 1 |
| Saito, Y | 1 |
| Suresh, P | 1 |
| Shirai, K | 1 |
| Soga, M | 1 |
| Nagai, Y | 1 |
| Takahashi, T | 2 |
| Hasegawa, G | 2 |
| Naito, M | 2 |
| Tachikawa, H | 1 |
| Tanabe, N | 3 |
| Kodama, M | 3 |
| Aizawa, Y | 3 |
| Yamaguchi, K | 1 |
| Miyazaki, M | 1 |
| Kakemi, M | 1 |
| Inoue, A | 1 |
| Yamashina, S | 1 |
| Yamazaki, J | 1 |
| Fukuchi, K | 1 |
| Yasumura, Y | 4 |
| Kiso, K | 1 |
| Hayashida, K | 1 |
| Miyatake, K | 4 |
| Ishida, Y | 4 |
| Kotlyar, E | 1 |
| Hayward, CS | 1 |
| Feneley, M | 1 |
| Macdonald, PS | 1 |
| Rusconi, P | 1 |
| Gómez-Marín, O | 1 |
| Rossique-González, M | 1 |
| Redha, E | 1 |
| Marín, JR | 1 |
| Lon-Young, M | 1 |
| Wolff, GS | 1 |
| Kasama, S | 2 |
| Kumakura, H | 2 |
| Takayama, Y | 2 |
| Ichikawa, S | 2 |
| Tange, S | 1 |
| Suzuki, T | 2 |
| Kurabayashi, M | 2 |
| Palloshi, A | 1 |
| Fragasso, G | 1 |
| Silipigni, C | 1 |
| Locatelli, M | 1 |
| Cristell, N | 1 |
| Pala, MG | 1 |
| Alfieri, O | 1 |
| Margonato, A | 1 |
| Sugioka, K | 3 |
| Hozumi, T | 3 |
| Takemoto, Y | 3 |
| Ujino, K | 1 |
| Watanabe, H | 1 |
| Fujimoto, K | 1 |
| Yoshiyama, M | 3 |
| Yoshikawa, J | 3 |
| Cinquegrana, G | 1 |
| D'Aniello, L | 1 |
| Landi, M | 1 |
| Spinelli, L | 1 |
| Grande, G | 1 |
| De Prisco, F | 1 |
| Petretta, M | 1 |
| Tatli, E | 2 |
| Kurum, T | 2 |
| Green, P | 1 |
| Anshelevich, M | 1 |
| Talreja, A | 1 |
| Burcham, JL | 1 |
| Ravi, SM | 1 |
| Shirani, J | 1 |
| Le Jemtel, TH | 1 |
| Inoue, K | 1 |
| Matsuo, S | 1 |
| Nakae, I | 1 |
| Masuda, D | 1 |
| Matsumoto, T | 3 |
| Horie, M | 1 |
| Gaibazzi, N | 1 |
| Rahko, PS | 1 |
| Belenkov, IuN | 1 |
| Belianko, IE | 1 |
| Gerasimova, VV | 1 |
| Dolotov, VK | 1 |
| Konstantinov, BA | 1 |
| Koroteev, AV | 1 |
| Kulagina, TIu | 1 |
| Mareev, VIu | 1 |
| Rebunenkov, GV | 1 |
| Sandrikov, VA | 1 |
| Skvortsov, AA | 1 |
| Sychev, AV | 1 |
| Tereshchenko, SN | 1 |
| Khovrin, VV | 1 |
| Patrianakos, AP | 1 |
| Parthenakis, FI | 1 |
| Mavrakis, HE | 2 |
| Diakakis, GF | 1 |
| Chlouverakis, GI | 1 |
| Vardas, PE | 2 |
| Chizzola, PR | 2 |
| Gonçalves de Freitas, HF | 1 |
| Marinho, NV | 2 |
| Mansur, JA | 1 |
| Meneghetti, JC | 1 |
| Bocchi, EA | 2 |
| Dzhaniashvili, MI | 1 |
| Chanturiia, NG | 1 |
| Panchulidze, GA | 1 |
| Paraskevaidis, IA | 1 |
| Tsiapras, D | 2 |
| Karavolias, G | 1 |
| Adamopoulos, S | 1 |
| Dodouras, T | 2 |
| Cokkinos, P | 1 |
| Kremastinos, DT | 2 |
| Nikolaidis, LA | 1 |
| Poornima, I | 1 |
| Parikh, P | 1 |
| Magovern, M | 1 |
| Shen, YT | 1 |
| Shannon, RP | 1 |
| Heringer-Walther, S | 1 |
| Moreira, Mda C | 1 |
| Wessel, N | 1 |
| Ventura, TM | 1 |
| Schultheiss, HP | 1 |
| Walther, T | 1 |
| Köhnlein, T | 1 |
| Welte, T | 1 |
| Nishioka, K | 1 |
| Nakagawa, K | 1 |
| Umemura, T | 1 |
| Jitsuiki, D | 1 |
| Ueda, K | 1 |
| Goto, C | 1 |
| Chayama, K | 1 |
| Yoshizumi, M | 1 |
| Higashi, Y | 1 |
| Neglia, D | 1 |
| De Maria, R | 1 |
| Masi, S | 1 |
| Gallopin, M | 1 |
| Pisani, P | 1 |
| Pardini, S | 1 |
| Gavazzi, A | 1 |
| L'abbate, A | 1 |
| Parodi, O | 1 |
| Mezzani, A | 1 |
| Corrà, U | 1 |
| Giordano, A | 1 |
| Cafagna, M | 1 |
| Adriano, EP | 1 |
| Giannuzzi, P | 1 |
| Takagi, Y | 1 |
| Abraham, TP | 1 |
| Oe, K | 1 |
| Yamagata, T | 1 |
| Mori, K | 1 |
| Paraskevaidis, I | 1 |
| Farmakis, D | 1 |
| Parissis, JT | 1 |
| Filippatos, G | 1 |
| Hatori, T | 1 |
| Sumino, H | 1 |
| Yuksel, M | 1 |
| Ehara, S | 1 |
| Ogawa, K | 1 |
| Iwata, S | 1 |
| Oe, H | 1 |
| Otsuka, R | 1 |
| Poltavskaia, MG | 1 |
| Syrkin, AL | 1 |
| Andreev, DA | 1 |
| Svet, AV | 1 |
| Sarkisova, EA | 1 |
| Kalashnikov, VIu | 1 |
| Malfatto, G | 1 |
| Branzi, G | 1 |
| Ciambellotti, F | 1 |
| Valli, P | 1 |
| Bizzi, C | 1 |
| Facchini, M | 1 |
| Rhodes, J | 1 |
| Margossian, R | 1 |
| Darras, BT | 1 |
| Colan, SD | 1 |
| Jenkins, KJ | 1 |
| Geva, T | 1 |
| Powell, AJ | 1 |
| Chen, L | 1 |
| Meyers, D | 1 |
| Javorsky, G | 1 |
| Burstow, D | 1 |
| Lolekha, P | 1 |
| Lucas, M | 1 |
| Semmler, AB | 1 |
| Savarimuthu, SM | 1 |
| Fong, KM | 1 |
| Yang, IA | 1 |
| Atherton, J | 1 |
| Galbraith, AJ | 1 |
| Parsonage, WA | 1 |
| Molenaar, P | 1 |
| Kanoupakis, EM | 1 |
| Manios, EG | 1 |
| Kallergis, EM | 1 |
| Lyrarakis, GM | 1 |
| Koutalas, EP | 1 |
| Berruezo, A | 1 |
| Brugada, J | 1 |
| Kaku, B | 1 |
| Nakatani, Y | 1 |
| Katsuda, S | 1 |
| Taguchi, T | 1 |
| Nitta, Y | 1 |
| Hiraiwa, Y | 1 |
| Bajcetic, M | 1 |
| Kokic Nikolic, A | 1 |
| Djukic, M | 1 |
| Kosutic, J | 1 |
| Mitrovic, J | 1 |
| Mijalkovic, D | 1 |
| Jovanovic, I | 1 |
| Simeunovic, S | 1 |
| Spasic, MB | 1 |
| Samardzic, R | 1 |
| Nardi, M | 1 |
| Kelly, DT | 1 |
| Christian, PE | 1 |
| Datz, FL | 1 |
| Mealey, PC | 1 |
| Olsen, SL | 1 |
| Lee, YC | 1 |
| Yoshikawa, T | 1 |
| White, M | 1 |
| Hattler, BG | 1 |
| Crisman, TS | 1 |
| Wright, DJ | 1 |
| Cooke, GA | 1 |
| Tan, LB | 1 |
| Garbellini, M | 1 |
| Boldi, E | 2 |
| Rosselli, F | 1 |
| Milan, E | 1 |
| Osterziel, KJ | 1 |
| Ghali, JK | 1 |
| Fazio, S | 1 |
| Palmieri, EA | 1 |
| Ferravante, B | 1 |
| Bonè, F | 1 |
| Biondi, B | 1 |
| Saccà, L | 1 |
| Böhm, M | 1 |
| Ettelbrück, S | 1 |
| Flesch, M | 1 |
| van Gilst, WH | 1 |
| Knorr, A | 1 |
| Maack, C | 1 |
| Pinto, YM | 1 |
| Paul, M | 1 |
| Teisman, AC | 1 |
| Zolk, O | 1 |
| Cohn, LJ | 1 |
| Di Lenarda, A | 1 |
| Sabbadini, G | 1 |
| Salvatore, L | 1 |
| Sinagra, G | 1 |
| Mestroni, L | 1 |
| Pinamonti, B | 1 |
| Gregori, D | 1 |
| Ciani, F | 1 |
| Muzzi, A | 1 |
| Klugmann, S | 1 |
| Camerini, F | 1 |
| Fesmire, SI | 1 |
| Marcoux, LG | 1 |
| Lyyski, DS | 1 |
| Sprague, MK | 1 |
| Kennedy, HL | 1 |
| Eichhorn, EJ | 1 |
| Hoffmann, J | 1 |
| Grimm, W | 1 |
| Menz, V | 1 |
| Hufnagel, G | 1 |
| Maisch, B | 1 |
| Fujimura, M | 1 |
| Nakatani, S | 3 |
| Komamura, K | 3 |
| Yamagishi, M | 3 |
| Garlichs, C | 1 |
| Daniel, WG | 1 |
| Agostini, D | 1 |
| Belin, A | 1 |
| Amar, MH | 1 |
| Darlas, Y | 1 |
| Hamon, M | 1 |
| Grollier, G | 1 |
| Potier, JC | 1 |
| Bouvard, G | 1 |
| Fauchier, L | 1 |
| Giraudeau, B | 1 |
| Noori, A | 1 |
| Lindenfeld, J | 2 |
| Wolfel, E | 1 |
| Modena, MG | 1 |
| Tagliamonte, E | 1 |
| Iacono, A | 2 |
| Ohta, Y | 1 |
| Nakazawa, M | 2 |
| Higuchi, H | 1 |
| Fuse, K | 2 |
| Ito, M | 1 |
| Hirono, S | 1 |
| Hanawa, H | 1 |
| Kato, K | 1 |
| Freitas, HF | 1 |
| Caldas, MA | 1 |
| da Costa, JM | 1 |
| Meneghetti, C | 1 |
| Mansur, AJ | 1 |
| Ramires, JA | 1 |
| Hirooka, K | 2 |
| Hanatani, A | 2 |
| Ochiai, N | 1 |
| Furukawa, K | 1 |
| Ebizawa, T | 1 |
| Yagi, T | 1 |
| Akashi, K | 1 |
| Azuma, A | 1 |
| Sugihara, H | 1 |
| Piccirillo, G | 1 |
| Luparini, RL | 1 |
| Celli, V | 1 |
| Moisè, A | 1 |
| Lionetti, M | 1 |
| Marigliano, V | 1 |
| Cacciafesta, M | 1 |
| Marinelli, G | 1 |
| Pavese, F | 1 |
| Skudicky, D | 1 |
| Bergemann, A | 1 |
| Sliwa, K | 1 |
| Candy, G | 1 |
| Sareli, P | 1 |
| Kawai, K | 1 |
| Hata, K | 1 |
| Takaoka, H | 1 |
| Kawai, H | 1 |
| Yokoyama, M | 1 |
| Nishi, I | 1 |
| Iida, K | 1 |
| Kawano, S | 1 |
| Masumi, T | 1 |
| Yamaguchi, I | 1 |
| Tsutamoto, T | 1 |
| Wada, A | 1 |
| Maeda, K | 1 |
| Mabuchi, N | 1 |
| Hayashi, M | 1 |
| Tsutsui, T | 1 |
| Ohnishi, M | 1 |
| Sawaki, M | 1 |
| Fujii, M | 1 |
| Yamamoto, T | 1 |
| Horie, H | 1 |
| Sugimoto, Y | 1 |
| Kinoshita, M | 1 |
| Cioffi, G | 1 |
| Stefenelli, C | 1 |
| Latini, R | 1 |
| Agarwal, AK | 1 |
| Venugopalan, P | 1 |
| Kondo, I | 1 |
| Mizushige, K | 1 |
| Nozaki, S | 1 |
| Iwado, Y | 1 |
| Hirao, K | 1 |
| Senda, S | 1 |
| Kohno, M | 1 |
| Matsuo, H | 1 |
| Hori, M | 1 |
| Wahed, MI | 1 |
| Ashino, H | 1 |
| Tazawa, S | 1 |
| Merlet, P | 1 |
| Hittinger, L | 1 |
| Dubois-Randé, JL | 1 |
| Castaigne, A | 1 |
| Hiasa, Go | 1 |
| Hiwada, K | 1 |
| Tsvetkova, T | 1 |
| Matsumura, T | 1 |
| Tsushima, K | 1 |
| Ohtaki, E | 1 |
| Misu, K | 1 |
| Tohbaru, T | 1 |
| Asano, R | 1 |
| Nagayama, M | 1 |
| Kitahara, K | 1 |
| Umemura, J | 1 |
| Sumiyoshi, T | 1 |
| Hosoda, S | 1 |
| Nakamura, K | 1 |
| Kusano, K | 1 |
| Nakamura, Y | 1 |
| Kakishita, M | 1 |
| Ohta, K | 1 |
| Nagase, S | 1 |
| Yamamoto, M | 1 |
| Miyaji, K | 1 |
| Saito, H | 1 |
| Morita, H | 1 |
| Emori, T | 1 |
| Matsubara, H | 1 |
| Toyokuni, S | 1 |
| Ohe, T | 1 |
| Müller-Beckmann, B | 2 |
| Minobe, W | 2 |
| Roden, R | 2 |
| Skerl, L | 2 |
| Klein, J | 2 |
| Handwerger, D | 2 |
| Port, JD | 2 |
| Buchwald, A | 1 |
| Unterberg, C | 1 |
| van der Does, R | 1 |
| Wiegand, V | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Characterization of Myocardial Interstitial Fibrosis and Cardiomyocyte Hypertrophy by Cardiac MRI In Heart Failure: Implication on Early Remodeling and on the Transition to Heart Failure[NCT03084679] | 90 participants (Anticipated) | Interventional | 2017-11-01 | Recruiting | |||
| Bisoprolol Plasma Residual Concentrations for the Optimization of Drug Management in Heart Failure With Mild to Reduced Ejection Fraction[NCT03644446] | 81 participants (Anticipated) | Observational [Patient Registry] | 2017-11-02 | Recruiting | |||
| Lung Water By Ultra-Sound Guided Treatment To Prevent Death and Cardiovascular Complications in High Risk End Stage Renal Disease Patients With Cardiomyopathy (Lust Study)[NCT02310061] | 383 participants (Actual) | Interventional | 2013-03-31 | Completed | |||
| Pulse Reduction On Beta-blocker and Ivabradine Therapy[NCT02973594] | Phase 4 | 28 participants (Actual) | Interventional | 2016-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for carvedilol and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
Comparative Efficacy of Different Drugs for the Treatment of Dilated Cardiomyopathy: A Systematic Review and Network Meta-analysis.
Topics: Cardiomyopathy, Dilated; Carvedilol; Humans; Ivabradine; Network Meta-Analysis; Randomized Controlle | 2023 |
Clinical efficacy of carvedilol treatment for dilated cardiomyopathy: A meta-analysis of randomized controlled trials.
Topics: Blood Pressure; Cardiomyopathy, Dilated; Carvedilol; Heart Rate; Humans; Randomized Controlled Trial | 2019 |
β₂ AR agonists in treatment of chronic heart failure: long path to translation.
Topics: Adrenergic beta-2 Receptor Agonists; Animals; Apoptosis; Carbazoles; Cardiomyopathy, Dilated; Carved | 2011 |
Carvedilol in heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Cardiomyopathy, D | 1993 |
What type of beta-blocker should be used to treat chronic heart failure?
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Humans; Metoprolol; Pr | 2000 |
50 trials available for carvedilol and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
Tenascin-C as predictor of left ventricular remodeling and mortality in patients with dilated cardiomyopathy.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Carbazoles; Cardiomyopathy, Dilat | 2013 |
Evaluation of beta-blockers on left ventricular dyssynchrony and reverse remodeling in idiopathic dilated cardiomyopathy: A randomized trial of carvedilol and metoprolol.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Biomarkers; Carbazoles; Cardiomyopathy, Dilate | 2014 |
Usefulness of carvedilol to abolish myocardial postsystolic shortening in patients with idiopathic dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Diastole; | 2009 |
[The effect of carvedilol on coronary flow reserve in patients with dilated cardiomyopathy].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Coronary | 2010 |
Therapeutic window for calcium-channel blockers in the management of dilated cardiomyopathy: a prospective, two-centre study on non-advanced disease.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Calcium Channel Blockers; Carb | 2010 |
Ivabradine, a novel heart rate slower: is it a sword of double blades in patients with idiopathic dilated cardiomyopathy?
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Benzazepines; Carbazoles; C | 2011 |
A randomised, placebo-controlled trial of carvedilol in early familial dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Echocardiograph | 2011 |
The effect of carvedilol treatment on chronic heart failure in pediatric patients with dilated cardiomyopathy: a prospective, randomized-controlled study.
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Cardiotonic Agents; Carvedilol; Ch | 2013 |
Use of thallium-201 myocardial scintigraphy for the prediction of the response to beta-blocker therapy in patients with dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Adult; Aged; Carbazoles; Cardiomyopathy, Dilated | 2002 |
Coordinate changes in Myosin heavy chain isoform gene expression are selectively associated with alterations in dilated cardiomyopathy phenotype.
Topics: Antihypertensive Agents; Atrial Natriuretic Factor; Biopsy; Calcium-Transporting ATPases; Carbazoles | 2002 |
Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial.
Topics: Adrenergic beta-Antagonists; Aged; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Female; Follow-U | 2003 |
Effect of beta-blockers on insulin resistance in patients with dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Echocardi | 2003 |
Use of 123I-MIBG scintigraphy to assess the impact of carvedilol on cardiac adrenergic neuronal function in childhood dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenergic alpha-Antagonists; Adrenergic Fibers; Carbazoles; Card | 2003 |
Efficacy of carvedilol treatment on cardiac function and cardiac sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with metoprolol therapy.
Topics: 3-Iodobenzylguanidine; Adrenergic Antagonists; Adult; Aged; Carbazoles; Cardiomyopathy, Dilated; Car | 2003 |
Effects of carvedilol therapy on restrictive diastolic filling pattern in chronic heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; C | 2004 |
Gated myocardial SPECT to predict response to beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Bisoprolol; Carbazoles; Cardiomyopathy, Dilat | 2004 |
Dobutamine stress 99mTc-tetrofosmin quantitative gated SPECT predicts improvement of cardiac function after carvedilol treatment in patients with dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Dobutamin | 2004 |
Early detection by the Tei index of carvedilol-induced improved left ventricular function in patients with heart failure.
Topics: Adrenergic alpha-Antagonists; Aged; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Diastole; Echoc | 2004 |
Early recovery of impaired coronary flow reserve by carvedilol therapy in patients with idiopathic dilated cardiomyopathy: a serial transthoracic Doppler echocardiographic study.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Flow Velocity; Carbazoles; Cardiac Volume; Cardiomyo | 2005 |
Effects of different degrees of sympathetic antagonism on cytokine network in patients with ischemic dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Echocardiography; Fema | 2005 |
A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carv | 2005 |
An echocardiographic analysis of the long-term effects of carvedilol on left ventricular remodeling, systolic performance, and ventricular filling patterns in dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Diastole; Echocardiogr | 2005 |
Comparative efficacy of nebivolol versus carvedilol on left ventricular function and exercise capacity in patients with nonischemic dilated cardiomyopathy. A 12-month study.
Topics: Benzopyrans; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Double-Blind Method; Ethanolamines; Ex | 2005 |
The effect of beta-adrenergic receptor antagonism in cardiac sympathetic neuronal remodeling in patients with heart failure.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Adult; Carbazoles; Cardiomyopathy, Dilated; Carv | 2006 |
The effect of carvedilol therapy on myocardial functional reserve in patients with advanced heart failure caused by nonischemic dilated cardiomyopathy.
Topics: Adult; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Female; Heart; Heart Failure; Humans; Male; | 2006 |
Carvedilol improves endothelium-dependent vasodilation in patients with dilated cardiomyopathy.
Topics: Acetylcholine; Adult; Aged; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Endothelium, Vascular; | 2007 |
Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy.
Topics: Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Coronary Circulation; Double-Blind Method; Female; | 2007 |
Beta-blocker therapy induces ventricular resynchronization in dilated cardiomyopathy with narrow QRS complex.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Carbazoles; Cardiomyopathy, Dilated; Carve | 2007 |
Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Carbazoles; Cardiom | 2007 |
[The effects of beta-adrenoblocker therapy on the physical working capacity of patients with chronic heart failure of various origin].
Topics: Activities of Daily Living; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Carbazoles; | 2007 |
Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Dos | 2008 |
Electrophysiological effects of carvedilol administration in patients with dilated cardiomyopathy.
Topics: Action Potentials; Adrenergic beta-Antagonists; Aged; Blood Pressure; Carbazoles; Cardiomyopathy, Di | 2008 |
Effects of carvedilol on left ventricular function and oxidative stress in infants and children with idiopathic dilated cardiomyopathy: a 12-month, two-center, open-label study.
Topics: Administration, Oral; Adolescent; Adrenergic beta-Antagonists; Blood Pressure; Carbazoles; Cardiomyo | 2008 |
Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Catheterization, Swan- | 1994 |
Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiac Catheterization; Cardiac Volume; Cardiomyopathy, Di | 1996 |
Second- and third-generation beta-blocking drugs in chronic heart failure.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Carbazoles; Cardiac Output, Low; Cardiomyopathy, Dilated; | 1997 |
[The effects of mid- and long-term administration (3-4 years) of carvedilol in patients with idiopathic dilated cardiomyopathy].
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Double-Blind Method; F | 1997 |
Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Cardiomyopathy, D | 1999 |
Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Female | 2000 |
Efficacy of carvedilol on complex ventricular arrhythmias in dilated cardiomyopathy: double-blind, randomized, placebo-controlled study.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; | 2000 |
Effects of carvedilol in heart failure due to dilated cardiomyopathy. Results of a double-blind randomized placebo-controlled study (CARIBE study).
Topics: Adrenergic beta-Antagonists; Adult; Aged; Carbazoles; Cardiac Output, Low; Cardiomyopathy, Dilated; | 2000 |
Dilated cardiomyopathy in dialysis patients--beneficial effects of carvedilol: a double-blind, placebo-controlled trial.
Topics: Adult; Aged; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Double-Blind Method; Echocardiography; | 2001 |
Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study.
Topics: Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Digoxin; | 2001 |
Using isoproterenol stress echocardiography to predict the response to carvedilol in patients with dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Contraind | 2001 |
Beneficial effect of carvedilol on heart rate response to exercise in digitalised patients with heart failure in atrial fibrillation due to idiopathic dilated cardiomyopathy.
Topics: Adult; Aged; Atrial Fibrillation; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Digitalis Glycosi | 2001 |
Comparative left ventricular functional and neurohumoral effects of chronic treatment with carvedilol versus metoprolol in patients with dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Adult; Atrial Natriuretic Factor; Carbazoles; Ca | 2001 |
Comparison of effects of carvedilol versus metoprolol on cytokine levels in patients with idiopathic dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Cytokines; Female; Hum | 2002 |
Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Calcium-Transporting ATPases; Carbazoles; Cardiomyopathy, | 2002 |
Carvedilol decreases elevated oxidative stress in human failing myocardium.
Topics: Adrenergic beta-Antagonists; Aldehydes; Antioxidants; Carbazoles; Cardiomyopathy, Dilated; Carvedilo | 2002 |
[Acute hemodynamic effects of the vasodilator beta blocker carvedilol in heart failure].
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Coronary Disease; Doub | 1990 |
81 other studies available for carvedilol and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
A Patient with Dilated Cardiomyopathy and Portal Hypertension: Which Beta-Blocker to Use?
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Clinical Decision-Maki | 2017 |
Improvement of the outcome in patients with infantile dilated cardiomyopathy over three decades - The usefulness of long-term gradually medical supportive care.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiac Resynchronization The | 2019 |
Clinical and echocardiographic outcome in patients receiving carvedilol for treatment of dilated cardiomyopathy.
Topics: Adolescent; Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Child; Chi | 2013 |
Effects of carvedilol therapy on cardiac autonomic control, QT dispersion, and ventricular arrhythmias in children with dilated cardiomyopathy.
Topics: Arrhythmias, Cardiac; Autonomic Nervous System; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Chi | 2013 |
Evaluation of global circumferential strain as prognostic marker after administration of β-blockers for dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Area Under Curve; Bisoprolol; Carbazoles; Cardiomyopathy, | 2014 |
Time course of left ventricular reverse remodeling in response to pharmacotherapy: clinical implication for heart failure prognosis in patients with idiopathic dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Dose-Response Relation | 2016 |
Left ventricular reverse remodeling with infantile dilated cardiomyopathy and pitfalls of carvedilol therapy.
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Dose-Response Relation | 2016 |
Successful treatment of arrhythmia-induced cardiomyopathy in an infant with tuberous sclerosis complex.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; | 2016 |
Pharmacological Modulation of Calcium Homeostasis in Familial Dilated Cardiomyopathy: An In Vitro Analysis From an RBM20 Patient-Derived iPSC Model.
Topics: Apoptosis; Calcium; Calcium Signaling; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Homeostasis; | 2016 |
Clinical and echocardiographic characteristics and outcomes in congestive heart failure at the Hospital of The State University of Haiti.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Age Distribution; Aged; Aged, 80 and over; Angiotens | 2016 |
Vidarabine, an Anti-Herpes Virus Agent, Protects Against the Development of Heart Failure With Relatively Mild Side-Effects on Cardiac Function in a Canine Model of Pacing-Induced Dilated Cardiomyopathy.
Topics: Animals; Antiviral Agents; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Disease Models, Animal; | 2016 |
Enalapril and losartan are more effective than carvedilol in preventing dilated cardiomyopathy in the Syrian cardiomyopathic hamster.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme | 2008 |
The effect of carvedilol therapy on coronary flow reserve in patients with idiopathic dilated cardiomyopathy.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Blood Flow Velocity; Carbazoles; Cardiomyopath | 2008 |
Severe left ventricular dysfunction in infants with ventricular preexcitation.
Topics: Adrenergic alpha-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Carbazoles; Cardiomyopathy, Dilate | 2008 |
Comparison of losartan and carvedilol on attenuating inflammatory and oxidative response and preserving energy transcription factors and left ventricular function in dilated cardiomyopathy rats.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Animals; Carbazoles; Cardiomyo | 2008 |
Myocardial beta-adrenergic receptor density assessed by 11C-CGP12177 PET predicts improvement of cardiac function after carvedilol treatment in patients with idiopathic dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Aged; Carbazoles; Carbon Radioisotopes; Cardiomyopathy, Dilated; Carved | 2009 |
Cardiac magnetic resonance imaging and management of dilated cardiomyopathy in a Duchenne muscular dystrophy manifesting carrier.
Topics: Adult; Biomarkers; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Child; Creatine Kinase; Disease | 2009 |
Isolated left ventricular hypertrabeculation/noncompaction in a Turner mosaic with male phenotype.
Topics: Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Cardiomyopathy, | 2009 |
Therapeutic effect of {beta}-adrenoceptor blockers using a mouse model of dilated cardiomyopathy with a troponin mutation.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Dis | 2009 |
Found in translation: metoprolol improves survival more than carvedilol in a mouse model of inherited dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Disease Model | 2009 |
Case of the month. Idiopathic dilated cardiomyopathy.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Angiography; Angiotensin-Converting | 2009 |
Effects of mechanical stress and carvedilol in lamin A/C-deficient dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Animals; Aorta, Thoracic; Apoptosis; Carbazoles; Cardiomyopathy, Dilate | 2010 |
Combined amiodarone and low-dose carvedilol treatment for severe heart failure in childhood.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Dos | 2010 |
Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Conve | 2011 |
Thrombolytic therapy for acute stroke in a teenager.
Topics: Adolescent; Aspirin; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Cerebral Angiography; Defibril | 2012 |
Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance.
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Female; Follow-Up Stud | 2003 |
Serum levels of matrix metalloproteinases and tumor necrosis factor-alpha in patients with idiopathic dilated cardiomyopathy and effect of carvedilol on these levels.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Female; H | 2003 |
Digoxin-carvedilol interactions in children.
Topics: Carbazoles; Cardiomyopathy, Dilated; Cardiotonic Agents; Carvedilol; Child; Child, Preschool; Digoxi | 2003 |
[Is "COMET" pointing in the right direction?--Pro].
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Dose-Response Relation | 2003 |
[Is "COMET" pointing in the right direction?--Con].
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Dose-Response Relation | 2003 |
Modulation of neurohormonal activity after treatment of children in heart failure with carvedilol.
Topics: Adrenergic beta-Antagonists; Adult; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Child; Child, P | 2003 |
Contribution of sympathetic nervous system activity during administration of carvedilol in rats with dilated cardiomyopathy.
Topics: Animals; Blood Pressure; Body Weight; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Dose-Response | 2003 |
The effect of beta-blocker on hamster model BIO 53.58 with dilated cardiomyopathy determined using 123I-MIBG myocardial scintigraphy.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Animals; Carbazoles; Cardiomyopathy, Dilated; Ca | 2003 |
The impact of baseline left ventricular size and mitral regurgitation on reverse left ventricular remodelling in response to carvedilol: size doesn't matter.
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Chronic Disease; Echoc | 2004 |
Carvedilol in children with cardiomyopathy: 3-year experience at a single institution.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, D | 2004 |
Long-term effects of carvedilol or metoprolol on left ventricular function in ischemic and nonischemic cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Carbazoles; Cardiomyopathy, Dilated; Ca | 2005 |
Effect of beta-blocker therapy on myocardial perfusion defects in thallium-201 scintigraphy in patients with dilated cardiomyopathy.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Carbazoles; Cardiomyopathy, Dilated; Carvedilo | 2005 |
Dilated cardiomyopathy relieved as a result of beta-blocker therapy: a case report--key points in assessment of prognosis based on MIBG myocardial scintigraphy and BNP levels.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; | 2005 |
Early detection by the Tei index of carvedilol-induced improved left ventricular function in patients with heart failure.
Topics: Adrenergic alpha-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Diastole; Echocardiog | 2005 |
[Implantation of an extracardiac mesh in the treatment of dilated cardiomyopathy: the TOLK Study (Therapevticheskoe Operativnoe Lechenie Kardiomyopatye)].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Di | 2005 |
[Clinical and hemodynamic efficiency of dilatrend treatment in patients with dilatation cardiomyopathy].
Topics: Adult; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Electrocardiography; Hemodynamics; Humans; M | 2005 |
The effects of combined versus selective adrenergic blockade on left ventricular and systemic hemodynamics, myocardial substrate preference, and regional perfusion in conscious dogs with dilated cardiomyopathy.
Topics: Adrenergic Antagonists; Adrenergic beta-Agonists; Animals; Carbazoles; Cardiomyopathy, Dilated; Carv | 2006 |
Does the C-type natriuretic peptide have prognostic value in chagas disease and other dilated cardiomyopathies?
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Carbazoles | 2006 |
Does beta-blocker treatment influence central sleep apnoea?
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiac Output, Low; Cardiomyopathy, Dilated; Carvedilol; C | 2007 |
Unreliability of the %VO2 reserve versus %heart rate reserve relationship for aerobic effort relative intensity assessment in chronic heart failure patients on or off beta-blocking therapy.
Topics: Adrenergic beta-Antagonists; Aged; Carbazoles; Cardiac Output, Low; Cardiomyopathy, Dilated; Carvedi | 2007 |
Decline of plasma brain natriuretic peptide level after carvedilol therapy to treat dilated cardiomyopathy presenting with mechanical alternans.
Topics: Adrenergic beta-Antagonists; Adult; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Electrocardiogr | 2007 |
Carvedilol improves left atrial and left ventricular function and reserve in dilated cardiomyopathy after 1 year of treatment.
Topics: Adrenergic beta-Antagonists; Adult; Atrial Function, Left; Carbazoles; Cardiomyopathy, Dilated; Card | 2007 |
Effects of carvedilol on plasma levels of pro-inflammatory cytokines in patients with ischemic and nonischemic dilated cardiomyopathy.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Carbazoles; | 2007 |
Relation of early improvement in coronary flow reserve to late recovery of left ventricular function after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Blood Flow Velocity; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; C | 2007 |
Different ventricular remodelling and autonomic modulation after long-term beta-blocker treatment in hypertensive, ischaemic and idiopathic dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Autonomic Nervous System; Carbazoles; Cardiomyopathy, Dilated; Carvedil | 2007 |
Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol.
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Echocardiography; Fema | 2007 |
Betablockers: is the reduction of sudden death related to pure electrophysiologic effects?
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Death, Sudden, Cardiac | 2008 |
Persistent left bundle branch block in a patient with dilated cardiomyopathy that improved with low dose carvedilol therapy.
Topics: Adrenergic alpha-Antagonists; Adult; Bundle-Branch Block; Carbazoles; Cardiomyopathy, Dilated; Carve | 2008 |
Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Diastole; Humans; Prop | 1997 |
Intractable recurrent ventricular tachycardia in dilated cardiomyopathy controlled by a vasodilating beta blocker.
Topics: Adrenergic beta-Antagonists; Adult; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Female; Humans; | 1997 |
Carvedilol in heart failure: the MOCHA trial.
Topics: Adrenergic Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Clinical Trials as Topic; D | 1997 |
Carvedilol and dose-related improvements in left ventricular function.
Topics: Adrenergic Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Clinical Trials as Topic; D | 1997 |
Doxorubicin-induced cardiomyopathy treated with carvedilol.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Antineoplastic Agents; Carbazoles; | 1998 |
Beta-adrenergic signal transduction following carvedilol treatment in hypertensive cardiac hypertrophy.
Topics: Adenylate Cyclase Toxin; Adenylyl Cyclases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; A | 1998 |
Carvedilol.
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Heart Failure; Hemodyn | 1999 |
Effect of selective versus nonselective beta blockade on QT dispersion in patients with nonischemic dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Death, Su | 1999 |
[Prospective evaluation of effect of carvedilol therapy on heart rate variability in patients with dilated cardiomyopathy].
Topics: Adrenergic beta-Antagonists; Adult; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Dose-Response R | 1999 |
Improvement in left ventricular function in response to carvedilol is accompanied by attenuation of neurohumoral activation in patients with dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Adult; Aged; Atrial Natriuretic Factor; Biomarke | 2000 |
[New milestones in the therapy of chronic heart failure with beta blockers].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; Carbazoles; Cardi | 2000 |
Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: a 123I-MIBG scintigraphic study.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenergic Antagonists; Adult; Aged; Aged, 80 and over; Carbazole | 2000 |
Beta-blockers and ventricular arrhythmias in dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; | 2000 |
Beta-blockade in adriamycin-induced cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antineoplastic Agents; Carbazoles; Cardiomyopathies; Cardi | 2000 |
Low dose carvedilol inhibits progression of heart failure in rats with dilated cardiomyopathy.
Topics: Animals; Body Weight; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Disease Progression; Endomyoc | 2000 |
Improvement in cardiac function and free fatty acid metabolism in a case of dilated cardiomyopathy with CD36 deficiency.
Topics: Adrenergic beta-Antagonists; Adult; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; CD36 Antigens; | 2000 |
[Is myocardial impairment in idiopathic dilated hypertrophic cardiomyopathy reversible by carvedilol?: a case report].
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Fatty Acids; Female; H | 2000 |
Effects of carvedilol on heart rate and blood pressure variability in subjects with chronic heart failure.
Topics: Adrenergic beta-Antagonists; Algorithms; Analysis of Variance; Baroreflex; Blood Pressure; Carbazole | 2000 |
Plasma brain natriuretic peptide as a novel therapeutic indicator in idiopathic dilated cardiomyopathy during beta-blocker therapy: a potential of hormone-guided treatment.
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Echocardiography; Elec | 2001 |
Relationship between tumor necrosis factor-alpha production and oxidative stress in the failing hearts of patients with dilated cardiomyopathy.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Carbazoles; Cardiomyopathy, Dilated; Carvedilo | 2001 |
[Reversibility of left ventricular dysfunction in elderly patients with dilated cardiomyopathy undergoing treatment with carvedilol. Report of a case].
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Carbazoles; Cardiomyopathy, Dilated; Carvedilo | 2001 |
[Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol. Results of a randomised study].
Topics: Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Humans; P | 2001 |
Ultrasonic tissue characterization can predict beta-blocker efficacy in dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; | 2001 |
Effects of carvedilol on cardiac function and cardiac adrenergic neuronal damage in rats with dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Adrenergic Fibers; Animals; Autoimmune Diseases; | 2002 |
Myocardial adrenergic dysinnervation in dilated cardiomyopathy: cornerstone or epiphenomenon?
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Adrenergic Fibers; Animals; Carbazoles; Cardiomy | 2002 |
Effects of carvedilol on plasma levels of interleukin-6 and tumor necrosis factor-alpha in nine patients with dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Female; Humans; Interl | 2002 |
Effects of carvedilol on adrenergic receptor pharmacology in human ventricular myocardium and lymphocytes.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Binding, Competitive; Carbazoles; Cardiomyopat | 1992 |
Receptor pharmacology of carvedilol in the human heart.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Binding, Competitive; Carbazoles; Cardiomyopat | 1992 |